CNBC: Investing

AUGUST 10, 2024

The Japanese pharmaceutical company is grappling with a scandal, and Oasis thinks it can help right the ship.

Pharmaceutical 98

Pharmaceutical IT 98

Global Newswire by Notified: M&A

MARCH 20, 2024

Nika Pharmaceuticals, Inc. OTCMKTS: NKPH) announces its merger with Nika BioTechnology, Inc., effective as of March 1, 2024.

Pharmaceutical 89

Pharmaceutical Mergers IT 89

JD Supra: Mergers

JULY 24, 2023

While the two companies evidently have some history together, this new deal is reportedly tied to Phillip Morris’ interest in acquiring Syqe’s metered-dose, pharmaceutical-grade inhaler that dispenses precise doses of medical cannabis to patients. By: Bradley Arant Boult Cummings LLP

Medical 246

Medical Pharmaceutical 246

PE Hub

JANUARY 3, 2024

The post Avista-backed Cosette Pharmaceuticals acquires women’s sexual health brand Vyleesi appeared first on PE Hub. The seller was Palatin Technologies Inc.

Pharmaceutical 84

Pharmaceutical 84

PE Hub

JANUARY 17, 2024

The post PE-backed Alcami acquires Pacific Pharmaceutical Services appeared first on PE Hub. Alcami is a contract development and manufacturing organization.

Pharmaceutical 76

Pharmaceutical Manufacturing 76

JD Supra: Mergers

APRIL 18, 2024

On March 26, 2024, Skadden hosted a discussion on key developments in antitrust enforcement in the pharmaceuticals and life sciences sectors. By: Skadden, Arps, Slate, Meagher & Flom LLP

Pharmaceutical 177

Pharmaceutical 177

JD Supra: Mergers

DECEMBER 12, 2024

But one portion of the pharmaceutical industry is bucking this trend in a major way. Over the past few years economic headwinds have resulted in fewer deals, with companies and private equity firms alike reassessing where to spend money.

Private Equity 183

Private Equity Pharmaceutical Economics Sale 183

Global Newswire by Notified: M&A

AUGUST 15, 2024

Protect Pharmaceutical Corp. PRTT) Announces New CEO and New Director; Moves to Finalize the Karinca Logistics Merger.

Pharmaceutical 85

Pharmaceutical Mergers 85

JD Supra: Mergers

JULY 10, 2024

Cephalon, Inc., 2018-0075-SG (Del. 30, 2024) - Stockholder representatives of an acquired corporation brought claims alleging that defendants had failed to use contractually-required commercially reasonable efforts to commercialize an acquired drug asset for a particular use. By: Morris James LLP

Pharmaceutical 165

Pharmaceutical Mergers Corporation 165

Global Newswire by Notified: M&A

JULY 28, 2023

Nasdaq: BIIB) and Reata Pharmaceuticals, Inc. CAMBRIDGE, Mass. and PLANO, Texas, July 28, 2023 (GLOBE NEWSWIRE) -- Biogen Inc. Nasdaq: RETA) today announced the companies have entered into a definitive agreement under which Biogen has agreed to acquire Reata for $172.50 per share in cash, reflecting an enterprise value of approximately $7.3

Pharmaceutical 76

Pharmaceutical Shares 76

JD Supra: Mergers

SEPTEMBER 27, 2024

On September 11-12, we had the pleasure of attending the LSX World Congress USA in Boston, where leaders discussed the challenges and opportunities of M&A and partnerships in the pharmaceutical sector. By: A&O Shearman

Pharmaceutical 165

Pharmaceutical M&A 165

JD Supra: Mergers

MAY 15, 2024

Bass, Berry & Sims brought a team of four attorneys from our Specialty Pharmacy & Pharmaceuticals and 340B Program Services practice groups to join the fun. Asembia’s 20th Annual Specialty Pharmacy Summit once again brought investors and operators in the specialty pharmacy ecosystem to Las Vegas for learning sessions and networking.

Pharmaceutical 177

Pharmaceutical Investors 177

JD Supra: Mergers

JANUARY 22, 2024

Morgan Healthcare Conference in San Francisco, which also saw the announcement of major acquisitions by large players in the pharmaceutical space. The timing of the announcement coincided with the start of the 42nd Annual J.P. By: Knobbe Martens

Pharmaceutical 183

Pharmaceutical Healthcare Corporation Equities 183

PE Hub

SEPTEMBER 22, 2023

The post Gurnet Point and Novo Holdings complete take-private buyout of Paratek Pharmaceuticals appeared first on PE Hub. The purchase price is about $462 million.

Pharmaceutical 79

Pharmaceutical 79

JD Supra: Mergers

MARCH 27, 2024

designs and produces solutions for the biopharmaceutical, pharmaceutical and medical device markets and aerospace industries. New Mountain Capital will sell ILC Dover to Ingersoll Rand for about $2.3 billion, according to industry reports. ILC, founded in 1947 and based in Frederica, Del., By: McGuireWoods LLP

Private Equity 159

Private Equity Pharmaceutical Healthcare Medical 159

JD Supra: Mergers

JANUARY 26, 2024

While the year saw an overall decline in M&A activity (down 17% from 2022), total pharmaceuticals and life sciences deal value in 2023 increased by approximately 50% compared to 2022. By: Cooley LLP

M&A 171

M&A Pharmaceutical Business 171

JD Supra: Mergers

FEBRUARY 5, 2024

The European Commission (EC) has published its latest report on competition enforcement in medicines and medical products. Key takeaways are that: EU and Member State authorities imposed multiple material antitrust fines from 2018-2022, totalling approx. EUR780 million. By: Allen & Overy LLP

Pharmaceutical 171

Pharmaceutical Medical IT 171

JD Supra: Mergers

SEPTEMBER 4, 2024

August 01, 2024: SEAM Group, a B2B business products and services company that provides safety, reliability, maintenance, and enterprise asset management services in the hospitality, food processing, and pharmaceutical industries, was acquired by ABB for an undisclosed amount.

M&A 171

M&A Hospitality Asset Management Pharmaceutical 171

JD Supra: Mergers

JULY 10, 2024

Among these are two cross-agency Requests for Information (RFIs) about anticompetitive transactions, an online portal to enable anyone to report anticompetitive business practices, a new Department of Justice (DOJ) task force and a new Federal Trade Commission (FTC) investigation into certain Teva Pharmaceuticals’ patent.

Pharmaceutical 171

Pharmaceutical Government Trading Business 171

JD Supra: Mergers

APRIL 23, 2024

We were fortunate to have a mix of expert perspectives at the table, representing large pharmaceutical companies, investors, By: Mintz Asset Sale,” with business development leaders from GSK, Johnson & Johnson, Locust Walk, and Astria Therapeutics.

Pharmaceutical 171

Pharmaceutical M&A Sale Investors 171

PE Hub

JUNE 6, 2023

The post Gurnet Point and Novo Holdings to acquire Paratek Pharmaceuticals for $462m appeared first on PE Hub. Oaktree Capital Management will provide $175 million in debt financing for this deal.

Pharmaceutical 74

Pharmaceutical Debt Finance Finance 74

CNBC: Investing

NOVEMBER 19, 2024

This pharmaceutical company's recent drug developments could spell more gains ahead, according to Jefferies.

Pharmaceutical 67

Pharmaceutical 67

CNBC: Investing

OCTOBER 16, 2023

Jefferies recommends maintaining a long-term outlook on this key pharmaceutical stock.

Pharmaceutical 142

Pharmaceutical Stock 142

CNBC: Investing

JULY 6, 2024

Nvidia is a fan of Recursion Pharmaceuticals. Data expected from the company will help determine valuations for stocks using AI to discover new drugs.

Pharmaceutical 134

Pharmaceutical Valuation Investors Stock 134

JD Supra: Mergers

SEPTEMBER 6, 2023

Nonetheless, on September 1, 2023, (the Friday before Labor Day), the FTC announced a conduct consent decree to end its challenge to the Amgen-Horizon pharmaceutical merger. By: Mintz - Antitrust Viewpoints

Mergers 177

Mergers Pharmaceutical IT 177

JD Supra: Mergers

OCTOBER 2, 2024

The reforms are particularly relevant to the technology and pharmaceutical. The UK DMCC forms part of a global trend to focus merger review increasingly on vertical concerns and concerns about eliminating nascent competition, including by so-called “killer acquisitions” of firms perceived as future competitive threats. By: Morgan Lewis

Mergers and Acquisitions 159

Mergers and Acquisitions Pharmaceutical Mergers Acquisitions 159

JD Supra: Mergers

DECEMBER 1, 2023

To that end, the DOJ recently announced its decision to decline to prosecute Lifecore Biomedical, a pharmaceutical and medical device manufacturer, despite evidence that employees of Lifecore’s former US subsidiary bribed Mexican government officials in violation of the Foreign Corrupt Practices Act.

M&A 171

M&A Pharmaceutical Medical Manufacturing 171

CNBC: Investing

MARCH 4, 2024

A major car stock and a pharmaceutical giant were part of the early morning analyst chatter Monday.

Stock 118

Stock Pharmaceutical Shares 118

Global Newswire by Notified: M&A

JULY 1, 2024

Protect Pharmaceutical Corp. Issues Corporate Update.

Pharmaceutical 49

Pharmaceutical Corporation 49

CNBC: Investing

SEPTEMBER 16, 2023

This could pave the way for some major changes at the pharmaceutical company. Elliott recently entered a cooperation agreement with Catalent.

Pharmaceutical 128

Pharmaceutical 128

PE Hub

NOVEMBER 14, 2023

The post Nordic Capital bets it can help the pharmaceutical industry speed up technology adoption appeared first on PE Hub. Nordic is acquiring the majority stake in IntegriChain, a Philadelphia-based provider of technology for the life sciences industry, from Accel-KKR.

Pharmaceutical 65

Pharmaceutical Capital IT 65

CNBC: Investing

FEBRUARY 16, 2024

Eli Lilly's 'diabesity' medications are positioning it to become the first pharmaceutical company to hit $1 trillion in market cap, Morgan Stanley said.

Pharmaceutical 113

Pharmaceutical Medical Stock IT 113

CNBC: Investing

NOVEMBER 27, 2023

Two of the biggest analyst calls on Monday came within the pharmaceutical and clean energy sectors.

Pharmaceutical 121

Pharmaceutical 121

JD Supra: Mergers

MAY 23, 2023

ACN, based in Dallas, is a clinical site platform serving patients, pharmaceutical sponsors and contract research organizations. Amulet Capital Partners has announced it has acquired Alliance Clinical Network (ACN). By: McGuireWoods LLP

Private Equity 130

Private Equity Healthcare Pharmaceutical Equities 130

CNBC: Investing

FEBRUARY 2, 2024

Analysts have grown increasingly bullish on Vertex Pharmaceuticals and Uber, among other companies that will issue their latest financials next week.

Pharmaceutical 111

Pharmaceutical 111

CNBC: Investing

FEBRUARY 20, 2024

Pharmaceutical stocks have exhibited positive relative strength in recent weeks after significant underperformance in the fourth quarter of last year.

Stock 108

Stock Pharmaceutical 108

CNBC: Investing

FEBRUARY 13, 2024

A tech giant and a major pharmaceutical company were among the biggest analyst calls Tuesday.

Pharmaceutical 105

Pharmaceutical 105